Mergers & Acquisitions

Filter

Current filters:

None

Popular Filters

851 to 875 of 918 results

Covidien to spin off pharmaceuticals business

16-12-2011

US medical products and generic drugmaker Covidien (NYSE: COV) says that it plans to spin off its pharmaceuticals…

CovidienGenericsMergers & AcquisitionsNeurologicalPharmaceutical

FTC stipulates divestments for Valeant acquisitions

14-12-2011

Canada’s Valeant Pharmaceuticals International (TSX: VRX) has been ordered by the USA’s Federal…

DermatologicalsDermikMergers & AcquisitionsNorth AmericaPharmaceuticalValeant Pharmaceuticals

Baxter to acquire Synovis

14-12-2011

The USA’s Baxter International (NYSE: BAX) said yesterday that it has reached agreement to acquire…

Baxter InternationalMergers & AcquisitionsPharmaceuticalSynovis Life Technologies

Actelion pulls out of Trophos option

13-12-2011

Switzerland-based Actelion (SIX: ATLN), Europe’s biggest biotech company, says that it has decided…

ActelionBiotechnologyLicensingMergers & AcquisitionsolesoximePharmaceuticalRare diseasesTrophos

Sinclair IS buys derma company

08-12-2011

UK specialty drugmaker Sinclair IS Pharma plc (AIM: SPH.L) has entered into an agreement to acquire USA-based…

Advanced Bio-TechnologiesDermatologicalsKelo-coteMergers & AcquisitionsPharmaceuticalSinclair IS Pharma

AstraZeneca expands in China, cuts back in USA

08-12-2011

It was a busy couple of days for Anglo-Swedish drug major AstraZeneca (LSE: AZN), with the company yesterday…

Asia-PacificAstraZenecaGenericsGuangdong BeiKang PharmaManagementMergers & AcquisitionsNorth AmericaPharmaceutical

Generic strategic alliances

07-12-2011

The generic drugs sector’s role as the provider of affordable drugs has widely benefitted public…

GenericsMergers & Acquisitions

Roche acquires Verum Diagnostica for 11 million euros

05-12-2011

Swiss drugs and diagnostics major Roche (ROG: SIX) has signed an agreement under which it will acquire…

Mergers & AcquisitionsPharmaceuticalRocheVerum Diagnostica

US Biotech scores wins in November, despite global economic turmoil, says Burrill

04-12-2011

Economic and political worries in Europe and the USA fuelled another month of wild gyrations in the stock…

BiotechnologyFinancialMergers & AcquisitionsNorth AmericaResearch

Actavis acquires Dutch company PharmaPack

04-12-2011

Iceland-headquartered generic drugmaker Actavis says it has acquired 100% of the shares in PharmaPack…

ActavisGenericsMergers & AcquisitionsPharmaPack

Further push into diagnostics as Affymetrix acquires eBioscience for $330 million

02-12-2011

USA-based Affymetrix (Nasdaq: AFFX) is taking another move into diagnostics, saying that it has signed…

AffymetrixeBioscienceMergers & AcquisitionsPharmaceutical

Further $100 million committed to AstraZeneca’s MedImmune Ventures

29-11-2011

Anglo-Swedish drug major AstraZeneca (LSE: AZN) revealed yesterday that it has committed an additional…

AstraZenecaFinancialMedImmuneMergers & AcquisitionsPharmaceutical

USA’s SOHM acquires Novatrend to expand presence in India

28-11-2011

California, USA-based generic drugmaker SOHM (Pinksheets: SHMN) has announced the acquisition of business…

Asia-PacificDermatologicalsGenericsMergers & AcquisitionsNovatrend MedicamentPharmaceuticalSOHM

Asahi Kasei Pharma expands into USA with acquisition of Artisan Pharma

24-11-2011

Mid-size Japanese drugmaker Asahi Kasei Pharma says it has acquired its US licensee Artisan Pharma, establishing…

Artisan PharmaAsahi KaseiMergers & AcquisitionsPharmaceuticalRecomodulin

Pfizer to buy Excaliard, gaining rights to Ph II skin scarring product

23-11-2011

Global pharma behemoth Pfizer (NYSE: PFE) says it has entered into a definitive agreement to acquire…

DermatologicalsExcaliard PharmaIsis PharmaceuticalsMergers & AcquisitionsPfizerPharmaceutical

UCB adds to CNS portfolio with acquisition of Lectus’ key pharmaceutical assets

23-11-2011

Belgian drugmaker UCB (Euronext Brussels: UCB) has acquired the key pharmaceutical assets of closely-held,…

Lectus TherapeuticsMergers & AcquisitionsNeurologicalPharmaceuticalResearchUCB

Gilead expands hepatitis C R&D portfolio with $11 billion buy of Pharmasset

22-11-2011

In its biggest M&D deal to date, Gilead Sciences (Nasdaq: GILD) says it has signed a definitive agreement…

Anti-viralsBiotechnologyGilead SciencesMergers & AcquisitionsmericitabinePharmaceuticalPharmasset

Valeant to acquire Australia’s iNova for up to $946 million

22-11-2011

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (NYSE: VRX and TSX: VRX) has signed…

BiotechnologyiNovaMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals

India’s new drug price control will damage pharma sector, says local Pfizer chief

20-11-2011

The recent moves by India’s government to control the prices of all 348 essential drugs – accounting…

Asia-PacificMergers & AcquisitionsPfizerPharmaceuticalPricing

Lupin acquires Japanese drugmaker I’rom Pharma

18-11-2011

Indian drugmaker Lupin (LOPN: BO) has entered into an agreement with Japanese health care provider I’rom…

Asia-PacificGenericsI'rom PharmaceuticalLupinMergers & Acquisitions

Italy’s Menarini takes giant step into Asia-Pacific, with acquisition of Invida

16-11-2011

Italy’s leading independent drugmaker Menarini says it has acquired the Singapore-based Invida Group,…

Asia-PacificInvidaMenariniMergers & AcquisitionsPharmaceutical

Galenica acquires Spanish JV Vifor Uriach and Grupo Uriach's primary care business

15-11-2011

Swiss drugmaker Galenica (SIX: GALN) has acquired all the outstanding shares of Vifor Uriach Pharma SL,…

GalenicaMergers & AcquisitionsPharmaceuticalUriach

Sinclair IS Pharma divests Mysoline to Lab SERB for £11 million

15-11-2011

UK specialty drugmaker Sinclair IS Pharma (AIM: SPH.L) says it has disposed of the epilepsy drug Mysoline…

Laboratoires SERBMergers & AcquisitionsMysolineNeurologicalPharmaceuticalSinclair IS Pharma

851 to 875 of 918 results

Back to top